Stereotactic radiotherapy for managing ovarian cancer oligoprogression under poly (ADP-ribose) polymerase inhibitors (PARPi).
Durante S, Cuccia F, Rigo M, Caminiti G, Mastroleo F, Lazzari R, Corrao G, Caruso G, Vigorito S, Cattani F, Ferrera G, Chiantera V, Alongi F, Colombo N, Jereczek-Fossa BA.
Durante S, et al. Among authors: caruso g.
Int J Gynecol Cancer. 2024 May 31:ijgc-2024-005361. doi: 10.1136/ijgc-2024-005361. Online ahead of print.
Int J Gynecol Cancer. 2024.
PMID: 38821546